Glycaemic control influences peripheral blood flow and haemorheological variables in patients with diabetes mellitus

Clinical Hemorheology and Microcirculation

Volumn 33, Issue 4, 2005, Pages 337-346

  Vigilance, Jacqueline E ^a   Reid, Harvey L ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Ankle blood flow; Glycaemic control; Plasma fibrinogen concentration; Relative plasma viscosity

Indexed keywords

FIBRINOGEN; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN; INSULIN; METFORMIN;

ADULT; AGED; ANKLE; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BLOOD FLOW; BLOOD RHEOLOGY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; LEG BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PLASMA VISCOSITY; VASODILATATION;

ADULT; AGED; BLOOD VISCOSITY; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; FIBRINOGEN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW;

EID: 28644445892     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. L. Olansky, Advances in diabetes for the millennium: chronic microvascular complications of diabetes, Med. Gen. Med. 6(2) (2004), 14.
2. I.M. Stratton, A.I. Adler, H.A.W. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner and R.R. Holman, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ 321(7258) (2000), 405-412.
3. J.W. Van-Wersch, S.H. Donders, L.W. Westerhuis and W.J. Venekaup, Microalbuminuria in diabetic patients: relationship to lipid glyco-metabolic, coagulation and fibrinolysis parameters, Eur. J. Clin. Chem. Clin. Biochem. 29(8) (1991), 493-498.
4. J. Pirat, Diabetes and its degenerative complications. A prospective study of 4,440 patients observed between 1974 and 1973, Diabetes Care 1 (1978), 168.
5. H.J.G. Gundersen, Peripheral blood flow and metabolic control in juvenile diabetes, Diabetologia 10 (1974), 225-231.
6. I. Yokoyama, T. Ohtake, S. Momomura, K. Yonekura, S. Woo-Soo, J. Nishikawa, Y. Sasaki and M. Omata, Hyperglycaemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM, Diabetes 47(1) (1998), 119-124.
7. M.D. Flynn, M. Boolell, J.E. Tooke and P.J. Watkins, The effect of insulin infusion in capillary blood flow in the diabetic neuropathic foot, Diabet. Med. 9(7) (1992), 630-634.
8. Y. Bahru, P. Kesteven, K.G. Alberti and M. Walke, Decreased plasminogen activator inhibitor-1 activity in newly diagnosed type 2 diabetic patients following dietary modification, Diabet. Med. 10(9) (1993), 802-806.
9. J.P. Vora, J. Dolben, J.D. Williams, J.R. Peters and D.R. Owens, Impact of initial treatment on renal function in newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia 36(8) (1993), 734-740.
10. P.I. Salmela, A.I. Oikarinen, O. Ukkola, A. Karajalainen, M. Linnaluoto, R. Puukka and L. Ryhanen, Improved metabolic control in patients with non-insulin-dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen, Eur. J. Clin. Invest. 25 (1995), 494-500.
11. P.J. Beisswenger, L.L. Moore and T.J. Curphey, Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes, Diabetes Care 16 (1993), 689-694.
12. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med. 329 (1993), 977-986.
13. H.L. Reid, J. Vigilance, R.A. Wright-Pascoe and E. Choo-Kang, The influence of persistent hyperglycaemia on hyperfibrinogenaemia and hyperviscosity in diabetes mellitus, West Indian Med. J. 49(4) (2000), 281-284.
14. G.D.O. Lowe, Blood rheology in arterial disease, Clin. Sci. 71 (1986), 137-146.
15. R.E. Maser, S.K. Wolfson, E. Demetrius, E.A. Stein, A.L. Drash, D.J. Becker, J.S. Dorman and T.J. Orchard, Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh epidemiology of diabetes complications study - V, Arteriosclerosis and Thrombosis 11 (1991), 958-965.
16. P.J. Osmundson, W.M. O'Fallon, B.R. Zimmerman, F.J. Kazmier, A.L. Langworthy and P.J. Palumbo, Course of peripheral occlusive arterial disease in diabetes. Vascular laboratory assessment, Diabetes Care 13 (1990), 143-152.
17. P.J. Dyck, Detection, characterization and staging of polyneuropathy: assessed in diabetics, Muscle & Nerve 11 (1988), 21-32.
18. J.E. Vigilance, H.L. Reid, J. Mills and P. Richards-George, Comparison of Doppler sphygmomanometry and venous occlusion air plethysmography in the diagnosis of peripheral occlusive arterial disease, J. Vasc. Tech. 23(4) (1999), 203-207.
19. F.G.R. Fowkes, E. Housley and G.C. Leng, Assessment of peripheral vascular disease in diabetics, Circulation 89(4) (1994), 1909-1910.
20. T.J. Orchard and D.E. Strandness, Assessment of peripheral vascular disease in diabetes: Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, Sept. 18-20, 1992, New Orleans, Louisiana, USA, Circulation 88(2) (1992), 819-828.
21. J.E. Vigilance, H.L. Reid, P. Richards-George and J. Mills, Impaired vasodilatory reserve in diabetics with and without neuropathy, Med. Sci. Res. 25(8) (1997), 561-564.
22. H.L. Reid and A.C. Ugwu, A simple technique for rapid determination of plasma viscosity, Nig. J. Physiol. Sci. 3 (1987), 45-48.
23. G.I.C. Ingram, A suggested schedule for the rapid investigation of acute haemostatic failure, J. Clin. Path. 14 (1961), 356-360.
24. R.R. Little, Glycated hemoglobin standardization - National Glycohemoglobin Standardization Program (NGSP) perspective, Clin. Chem. Lab. Med. 41(9) (2003), 1191-1198.
25. P. Fasching, S. Kurzemann, B. Wagner, O. Wagner, W. Waldhausl, H. Ehringer and R. Koppensteiner, Only marginal influence of metabolic control on blood rheology in insulin-dependent diabetic patients without manifest angiopathy, Clin. Hemorheol. 15(1) (1995), 3-11.
26. C. Renaudin, E. Michoud, J.R. Rapin, M. Lagarde and N. Wiernsperger, Hyperglycaemia modifies the reaction of microvessels to insulin in rat skeletal muscle, Diabetologia 41 (1998), 26-33.
27. 1c in the Diabetes Control and Complications Trial, Diabetes Care 25 (2002), 275-278.
28. W.G. Mayhan and K.P. Patel, Acute effects of glucose on reactivity of cerebral microcirculation: role of activation of protein kinase C, Am. J. Physiol. 269(4 Pt 2) (1995), H1297-H1302.
29. E.R. Mathiesen, J. Hilsted, B. Feldt-Rasmussen, F. Bonde-Petersen, N.J. Christensen and H.H. Parving, The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients, Diabetes 34(12) (1985), 1301-1305.
30. A.P. Brooks, I.M. Nairn and J.D. Baird, Changes in glycosylated haemoglobin after poor control in insulin-dependent diabetics, BMJ 281 (1980), 707-710.
31. C. Le Devehat, T. Khodabandehlou, H. Zhao and M. Vimeux, Role and limits of glycemic regulation in the pathogenesis of diabetic microangiopathy, Clin. Hemorheol. 17 (1997), 363-370.
32. J.L. Wautier, D. Pintigny, M.P. Wautie, R.C. Paton, F. Galacteros, P. Passa and J.P. Caln, Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium, J. Lab. Clin. Med. 101 (1983), 911-920.
33. M.V. Kulkarini and R.R. Puniyani, Study of hemorheological parameters in maturity-onset diabetic cases, Clin. Hemorheol. Microcirc. 14(2) (1994), 271-278.
34. S.M. MacRury, J.C. Lockhart, M. Small, A.I. Weir, A.C. MacCuish and G.D.O. Lowe, Do rheological variables play a role in diabetic peripheral neuropathy?, Diabetic Medicine 8(3) (1991), 232-236.
35. T. Khodabandehlou, C. LeDevehat and M. Razavian, Impaired function of fibrinogen: consequences on red cell aggregation in diabetes mellitus, Clin. Hemorheol Microcirc. 16(3) (1996), 303-312.
36. E. Vicaut, Opposite effects of red blood cell aggregation on resistance to blood flow, J. Cardiovasc. Surg. 36 (1995), 361-368.
37. R. Giansanti, R.A. Rabini, M. Boemi and P. Fumelli, Blood rheology changes and disturbances in microcirculation, Clin. Hemorheol. Microcirc. 16(4) (1996), 543-548.
38. Z. Marton, G. Kesmarky, J. Vekasi, A. Cser, R. Russai, B. Horvath and K. Toth, Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods, Clin. Hemorheol. Microcirc. 24(2) (2001), 75-83.
39. K. Elishkevitz, R. Fusman, M. Koffler, I. Shapira, D. Zeltser, D. Avitzour, N. Arber, S. Berliner and R. Rotstein, Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control, Diabet Med. 19(2) (2002), 152-156.
40. A. Lutjens, A.A. TeVelde, E.A. Veen and J.V.D. Meer, Glycosylation of human fibrinogen in vivo, Diabetologia 28 (1985), 87-89.